“Debt” can be a scary word for just about anyone. But as a startup investor, debt can be a welcome metric to evaluate the potential of an early-stage company. Long-term debt in particular is one of the first financial metrics I consider. It can help investors gauge a company’s general financial health, solvency risk, and how far its cash might stretch. Before we dig into the Chart of the Week, let’s look at what long-term debt is.
Startups using Regulation Crowdfunding to raise capital have to split their debt into short- and long-term. Short-term debt needs to be settled in a year, and long-term debt refers to debt that “matures in more than one year.” Growing a company from scratch takes a lot of capital, so it’s normal for startups to take on long-term debt. Companies can use debt to support research and product development, payroll, legal fees, marketing, and equipment while they are still pre-revenue. For some companies, achieving revenue takes years.
This week, I took a look at average long-term debt across different product types: software, hardware and consumer packaged goods (CPG), service, and pharmaceutical. And I was pretty surprised by what I found. Initially, I expected hardware and pharmaceutical companies to have the most long-term debt. Due to inventory needs and cost of goods sold, hardware-focused startups are often quite capital intensive. Similarly, pharmaceutical companies often spend years in research and development. They often need a lot more time to bring products to market and generate revenue due to regulatory hurdles. Funding clinical trials and iterating on a product would force companies to take on large amounts of debt. I assumed that keeping up with payroll and other expenses throughout the pre-product years would result in long-term debts for pharmaceutical and hardware startups. But that’s not what our data shows.
Surprisingly, hardware and pharmaceutical companies actually had the least amount of long-term debt with averages of $516,443.03 and $456,405.61, respectively. Service and software companies both averaged more than $550,000. (Notably, there were also far fewer pharmaceutical and service startups than hardware and software startups.)
I have a theory as to why my initial assumptions were so off. And I think it has a lot to do with the nature of the online private markets. Online startup investing is commonly used by very early-stage startups, often as one of the first rounds of funding. These raises can occur within a year or two of the company’s inception. And across the different product categories, company growth in those early days likely varies significantly.
Scaling a software company probably takes less time than scaling a hardware or pharmaceutical company. A software company that has been around for one year could already be going to market, whereas a medical device may just be in the ideation phase. Similarly, a hardware company may spend its early years prototyping its product before ramping up manufacturing. While it could be easy to bootstrap a software product, a software company that’s ready to go to market is likely to have many new expenses that could drive long-term debt.
Service-based startups had the highest amount of long-term debt on average. I think this is probably because they burn a significant amount of capital on payroll. Human resources can be very capital intensive, making this result less surprising than software surpassing hardware.
If long-term debt is something that you weigh as an investor, it may be worth examining it through the lens of product. And this data shows that our base assumptions aren’t always proven by what is actually happening in the market. That’s why I would encourage you to challenge assumptions and look at the online startup investing ecosystem as a whole. This practice has made me a more informed investor and pushed me to think deeply about the nascent and exciting world of the online private markets. Happy investing!
Note: All data on online startup investing used for the Chart of the Week comes from the KingsCrowd database and represents a snapshot of the US crowdfunding market.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
About: Olivia Strobl
Olivia comes to KingsCrowd with a background in venture capital and technology. She spent time at Glasswing Ventures, an AI-focused venture fund in Boston, before joining the KingsCrowd team. There she helped develop machine learning algorithms for the opportunity qualification of preseed and seed-stage startup companies. Prior to her time at Glasswing, Olivia worked in a lab studying the neural correlates of attention. She holds a degree in Neuroscience from Wellesley College.